These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35212454)

  • 1. Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis.
    Yang Y; Du J; Wang YS; Kang HY; Zhai K; Shi HZ
    Clin Transl Sci; 2022 Jun; 15(6):1340-1354. PubMed ID: 35212454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
    Xu K; Wang Y; Qi J; Zhao L; Wang P
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment.
    Wang TF; Chu SC; Lee JJ; Yang GG; Huang WH; Chang ET; Low T; Wu YF; Kao RH; Lin CB
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):304-313. PubMed ID: 28124437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis.
    Peng P; Yang Y; Du J; Zhai K; Shi HZ
    Cancer Cell Int; 2022 Feb; 22(1):99. PubMed ID: 35209915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
    Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
    Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.
    Tian L; Zeng R; Wang X; Shen C; Lai Y; Wang M; Che G
    Oncotarget; 2017 Jul; 8(28):46425-46435. PubMed ID: 28507279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.
    Rathore SS; Hussain N; Manju AH; Wen Q; Tousif S; Avendaño-Capriles CA; Hernandez-Woodbine MJ; Rojas GA; Vatsavayi P; Tera CR; Ali MA; Singh R; Saleemi S; Patel DM
    J Med Virol; 2022 Jan; 94(1):229-239. PubMed ID: 34449896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
    Creaney J; Dick IM; Segal A; Musk AW; Robinson BW
    Lung Cancer; 2013 Dec; 82(3):491-8. PubMed ID: 24161718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.
    Yoshimura A; Yamada T; Tsuji T; Hamashima R; Shiotsu S; Yuba T; Takumi C; Uchino J; Hiraoka N; Takayama K
    Thorac Cancer; 2019 Mar; 10(3):557-563. PubMed ID: 30672656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex Soluble Biomarker Analysis from Pleural Effusion.
    Javadi J; Dobra K; Hjerpe A
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32731396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
    Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
    Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis.
    Zhuo Y; Lin L; Wei S; Zhang M
    Medicine (Baltimore); 2016 Dec; 95(52):e5706. PubMed ID: 28033270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis.
    Feng S; Mu H; Hou R; Liu Y; Zou J; Zhao Z; Zhu Y
    Int J Clin Oncol; 2022 Jul; 27(7):1127-1138. PubMed ID: 35604501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
    Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
    Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Xu Y; Zhang Y; Wang X; Kang J; Liu X
    BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
    Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
    Jin L; Gu W; Li X; Xie L; Wang L; Chen Z
    Ther Adv Med Oncol; 2020; 12():1758835920962362. PubMed ID: 33062064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
    Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
    Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.